Showing results (381-390 of 434) with videos related to

Sort By:
Pageof 44
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2011
Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavirValerie A Gruber, Petrie M Rainey, David E Moody, et al.
The Journal of Infectious Diseases|September 18, 2013
Safety and antiviral activity of the HCV entry inhibitor ITX5061 in treatment-naive HCV-infected adults: a randomized, double-blind, phase 1b studyMark S Sulkowski, Minhee Kang, Roy Matining, et al.
Antiviral Research|April 25, 2000
Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies. The ACTG 187 and 199 study teamsG D Morse, R C Reichman, M A Fischl, et al.
Current Vascular Pharmacology|January 7, 2016
Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related DisordersCindy Bednasz, Amneris E Luque, Barry S Zingman, et al.
Clinical Drug Investigation|January 15, 2013
Indinavir Pharmacokinetics during Different Phases of the Menstrual Cycle in HIV-Infected WomenCharles E Frost, John Adams, Mark Shelton, et al.
Journal of Medicinal Chemistry|April 28, 2020
Synthetic Approaches to New Drugs Approved during 2018Andrew C Flick, Carolyn A Leverett, Hong X Ding, et al.
Journal of Community Health|February 1, 2024
Trusted Information Sources About the COVID-19 Vaccine Vary in Underserved CommunitiesBrian R Benson, Syed A Rahman, Jacob Bleasdale, et al.
Therapeutic Drug Monitoring|September 28, 2007
Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoringJudianne Slish, Qing Ma, Barry S Zingman, et al.
Pharmacogenomics|February 28, 2007
Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIVQing Ma, Daniel Brazeau, Barry S Zingman, et al.
ACS Infectious Diseases|February 25, 2025
Immunomodulatory Nanoparticles Induce Autophagy in Macrophages and Reduce <i>Mycobacterium tuberculosis</i> Burden in the Lungs of MiceRaymonde B Bekale, Retsepile E Maphasa, Sarah D'Souza, et al.
Pageof 44